Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Invitro InternationalIVRO -1.27% Intrinsic Value: Projected FCF is $-0.32 as of Aug. 31, 2026. The stock has 1 warning sign investors should review. Among 107 Medical Diagnostics & Research companies, Invitro International ranks worse than 934578.5% on this metric.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
The historical rank and industry rank for Invitro International's Intrinsic Value: Projected FCF or its related term are showing as below:
IVRO's Price-to-Projected-FCF is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 1.49 * Ranked among companies with meaningful Price-to-Projected-FCF only.
Invitro International (OTCPK:IVRO) Intrinsic Value: Projected FCF Explanation
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
Invitro International's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF
=
Share Price
/
Intrinsic Value: Projected FCF
=
0.078
/
-0.31962279853098
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Invitro International Intrinsic Value: Projected FCF Related Terms
Invitro International Intrinsic Value: Projected FCF Historical Data
* Premium members only.
The historical data trend for Invitro International's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Invitro International Intrinsic Value: Projected FCF Chart
IVRO vs IDTA, FUNI, BIAF: Intrinsic Value: Projected FCF Comparison
For the Diagnostics & Research subindustry, Invitro International's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Invitro International Price-to-Projected-FCF vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Invitro International's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where Invitro International's Price-to-Projected-FCF falls into.
Invitro International Intrinsic Value: Projected FCF Calculation
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Intrinsic Value: Projected FCF of $-0.32 mean?
Invitro International (IVRO) has a Intrinsic Value: Projected FCF of $-0.32 as of Aug. 31, 2026. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Invitro International and its competitors. According to the industry distribution chart, Invitro International ranks #999999 out of 107 companies in the Medical Diagnostics & Research industry.
Is Invitro International's Intrinsic Value: Projected FCF too high?
Invitro International's current Intrinsic Value: Projected FCF is $-0.32. Based on the distribution chart, Invitro International ranks #999999 out of 107 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Invitro International's Intrinsic Value: Projected FCF compare to IDTA and FUNI?
According to the Medical Diagnostics & Research industry distribution chart, Invitro International ranks #999999 out of 107 companies for Intrinsic Value: Projected FCF. This places Invitro International in the lower half of its industry. The industry median Intrinsic Value: Projected FCF is 1.49. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Intrinsic Value: Projected FCF for a Medical Diagnostics & Research company?
The median Intrinsic Value: Projected FCF among Medical Diagnostics & Research companies is 1.49, based on 107 companies in the industry. Companies in the top quartile (top 25%) have a Intrinsic Value: Projected FCF significantly above this median, while those in the bottom quartile fall well below. However, Intrinsic Value: Projected FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Intrinsic Value: Projected FCF mean?
A high Intrinsic Value: Projected FCF can signal that a stock is expensive relative to its fundamentals. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Invitro International and its competitors. For the Medical Diagnostics & Research industry, the median Intrinsic Value: Projected FCF is 1.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Invitro International's current Intrinsic Value: Projected FCF is $-0.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Invitro International stock overvalued right now?
Based on GuruFocus' analysis, Invitro International (IVRO) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.06, compared to a current price of $0.08 — trading 30% above its estimated fair value. The current Intrinsic Value: Projected FCF is $-0.32. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Intrinsic Value: Projected FCF calculated?
Intrinsic Value: Projected FCF is calculated from a company's financial statements. For Invitro International (IVRO), the current Intrinsic Value: Projected FCF is $-0.32 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Invitro International is a provider of non-animal testing methods. The company develops and commercializes test kits and laboratory services. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its products and services include Irritection, Corrositex, and Lab Services. The company provides its products to various industries such as cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation. The majority of its revenue is generated from the United States and it also exports to other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IVRO has been successfully added to your 
